Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for ...

Molecular glue-focused biotech f5 Therapeutics has failed to stick around for the long haul, shuttering after six years, according to an ...

We're also trying to make sure we look back at some of the trades that are still alive so we can keep you posted. We wrote ...

Investors are increasingly wary of the rare-disease space, spooked by a regulatory shift.

Evommune has two autoimmune disorder treatments with blockbuster potential.

Some artificial intelligence (AI)-focused companies have delivered exceptional returns over the past few years, but some investors and analysts now believe we are in an AI bubble ready to burst. Even ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Building a big nest egg for your post-work life by buying stocks is very possible, but it requires patience, investing in the ...

Federal lawmakers and business experts are visiting Augusta to see how a factory's production methods can boost American manufacturing independence.

The move comes as BioNTech shifts to being a multiproduct commercial biotech, allowing Ugur Sahin and Özlem Türeci to transition back into research on next-generation mRNA therapeutics.

With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter, ...

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.